NCT05951998 is a clinical trial in H.Pylori Infection, sponsored by Assiut University.

Who is sponsoring NCT05951998?

NCT05951998 is sponsored by Assiut University.

What condition does NCT05951998 study?

NCT05951998 studies H.Pylori Infection.

Is NCT05951998 still recruiting?

NCT05951998 is currently status unknown. Last updated 19 July 2023.

Last reviewed 2023-07-19 · How we verify

NCT05951998

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Frequency of h.Pylori in Children With Dyspeptic Symptoms

Status unknown Last updated 19 July 2023

What this trial tests

trial in H.Pylori Infection in 100 participants. Status unknown.

Timeline

1 August 2023

Primary endpoint
1 January 2024

1 June 2024

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	1 August 2023
Primary completion	1 January 2024
Estimated completion	1 June 2024

Conditions studied

H.Pylori Infection — all drugs for H.Pylori Infection →

Sponsor

Assiut University

Who can join

Adults 3 to 18, any sex, with H.Pylori Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The current work aim to: Estimation of prevalence, Estimation of risk factors, Estimation of endoscopic picture of H. pylori infection in children presented with chronic or recurrent dyspeptic symptoms and/or non variceal hematemesis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for H.Pylori Infection

Currently open trials in the same condition.

NCT07344506 — CURE-H. Pylori: A Trial on the Combination of Anti-Ulcerants and Levofloxacin-Based Therapy for Helicobacter Pylori Erad · Phase 4 · recruiting
NCT06950489 — Tegoprazan and Amoxicillin Dual Therapy · recruiting
NCT06682533 — Tegoprazan- Versus PPI-based H. Pylori Eradication · recruiting
NCT06684860 — RUT vs. Molecular Testing for H. Pylori · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05951998 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 19 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05951998.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing